| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 7 | |
| #2 | United States | 6 | |
| #3 | EPO (European Patent Office) | 4 | |
| #4 | Canada | 2 | |
| #5 | China | 2 | |
| #6 | Japan | 2 | |
| #7 | United Kingdom | 1 | |
| #8 | Israel | 1 | |
| #9 | India | 1 | |
| #10 | Republic of Korea | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry | |
| #3 | Chemical engineering |
| # | Name | Total Patents |
|---|---|---|
| #1 | Hanna Mazen | 22 |
| #2 | Shan Ning | 20 |
| #3 | Weyna David R | 12 |
| #4 | Cheney Miranda L | 12 |
| #5 | Houck Raymond K | 8 |
| #6 | Weyna David | 6 |
| #7 | Cheney Miranda | 6 |
| #8 | Houck Raymond | 3 |
| #9 | Mazen Hanna | 3 |
| #10 | Sun Xufeng | 2 |
| Publication | Filing date | Title |
|---|---|---|
| US2016016982A1 | Crystallization method and bioavailability | |
| WO2012071517A2 | Novel crystalline forms | |
| EP2458996A1 | Novel oral forms of a phosphonic acid derivative | |
| EP2400848A1 | Crystallization of pharmaceutical compounds | |
| EP2244712A1 | In vivo studies of crystalline forms of meloxicam | |
| GB0702402D0 | Method of creating crystalline substances |